KPTI insider trading
Karyopharm Therapeutics Inc.
In the past 36 days, 1 insider sold $450.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Kristin Abate Chief Accounting Officer |
$450 378 sh @ $1.19 |
−1.6% | Not pre-scheduled | Oct 1, 2026 Filed Oct 2, 2026 |